Thymosin Alpha-1

Immune-modulating peptide with decades of clinical use in chronic infection and cancer-adjunct settings.

Overview

Thymosin Alpha-1 (Tα1) is a synthetic analog of a peptide naturally produced by the thymus gland. It has decades of clinical use, particularly in chronic hepatitis and as a cancer-treatment adjunct - it's approved for specific indications in 35+ countries outside the US. Under the 2026 reclassification, it's now a Category 1 peptide available via 503A compounding pharmacies.

The primary mechanism is T-cell maturation support. Tα1 helps the thymus convert immature lymphocytes into functional T-cells, restoring immune function in contexts where it's depleted (chronic infection, aging, stress, cancer therapy). This makes it one of the most clinically validated peptides in the immune category.

In optimization use, it's typically cycled for immune resilience - post-illness recovery, chronic low-grade infection concerns (EBV, CMV, Lyme), or preventative support in high-stress periods.

Mechanism of Action

Tα1 stimulates the maturation of bone-marrow lymphocytes into functional T-cells, enhances NK cell activity, and modulates cytokine signaling to rebalance Th1/Th2 response. In chronic-infection contexts, it supports the Th1 (cellular) arm that's often depleted.

Community Usage Patterns

1.6 mg SC, 2× per week is the most common protocol. Some immune-focused protocols run 600 mcg daily or 3 mg twice-weekly. Cycles typically 12–24 weeks. Common combos: with peptides for chronic infection workups, or post-illness for recovery support. Effects are often subjective (fewer illnesses, faster recovery) rather than lab-visible, but hs-CRP and NK cell panels can show changes.

Education only - not medical advice. Any protocol change should involve your licensed provider.

Biomarkers to Track

When running Thymosin Alpha-1, these are the biomarkers most commonly tracked to assess response and safety:

Reconstitution Calculator

Free calculator for Thymosin Alpha-1 reconstitution math - vial size, BAC water volume, and exact syringe units.

Side Effects & Monitoring

What Thymosin Alpha-1 side effects are commonly reported, when they appear, the red flags worth a provider call, and the biomarkers that catch issues early.

Results & What to Track

What Thymosin Alpha-1 results actually look like in the data - the markers to measure, when they tend to move, and how to tell a real result from placebo.

Related Peptides

Stacks That Include Thymosin Alpha-1

Conditions Thymosin Alpha-1 is Commonly Researched For

Log doses, upload your lab PDFs, and let StackAI read your panel in context of what you're actually running. Free to start.